Dr. Xiaoyan Li, MD, PhD

Dr. Li practices at Duke University Hospital in Durham, North Carolina, part of Duke University.

Dr. Li's NPI, 1073909255, was assigned on April 14, 2015. Dr. Li holds North Carolina license 2019-00542.

Dr. Li's primary practice is Duke University Hospital, at 2301 Erwin Rd, Durham, NC 27705 in Durham County. The practice phone is (919) 684-8111.

Dr. Li's primary practice is Duke University Hospital in Durham, North Carolina, part of Duke University. The medical group on file is Duke Health Integrated Practice. Dmand AI also links Dr. Li to 2 more group practices and clinics, 1 hospice and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Li practices, 4 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Li's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Li is board certified in neuromuscular medicine by the American Board of Physical Medicine and Rehabilitation. Dr. Li is licensed in North Carolina.

CMS data shows 395 Medicare services from Dr. Li across 4 procedure codes in 2024, for 119 Medicare patients. Medicare paid $21,421 for them.

CMS counts 119 Medicare patients who saw Dr. Li in 2024. The largest group is 65 to 74, with 43 patients. 62% of them have high blood pressure, and 61% have high cholesterol. 12% are also on Medicaid. Their average risk score is 1.98, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Li's median patient age at 69, with 39% women.

In 2024, Dr. Li wrote 541 Medicare Part D claims for 99 patients. 65% of them were for generic drugs. CMS names the drug for 454 of them, across 10 drugs with 11 or more claims each, at $1,983,607 in total drug cost. In 2023, CMS named 462 claims across 13 drugs.

Dr. Li accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 186 papers to Dr. Li, published from 2011 to 2025. 2017 was the busiest year, with 17. The most frequent topics are Electromyography, Muscle, Skeletal and Stroke. Dr. Li has published most often in PLoS One. Dr. Li's most frequent co-authors are Ping Zhou, MD, William Rymer, MD and Richard Stanley Bedlack, MD, PhD.

Dmand AI links Dr. Li to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Amyotrophic Lateral Sclerosis and TDP-43 Proteinopathies.

CMS Open Payments shows 6 general payments to Dr. Li from 5 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 100% of the total. Biogen, Inc. paid the most, $135.